Apr 08,2026

Unleashing Platform-Level Innovation Capabilities in Antiserum Development | Jiangxi Bio Invited to Attend the Jiangxi Provincial Symposium on the Development of the Future Biopharmaceutical Industry

On March 31, 2026, Yin Hong, Secretary of the Jiangxi Provincial Party Committee, chaired a symposium on the development of the future bio–biopharmaceutical industry. Jiangxi Bio, as a key biopharmaceutical enterprise in Jiangxi Province, was invited to attend and engaged in discussions on industry development alongside leading companies such as Renhe Group and China Resources Jiangzhong.

See more+

Feb 27,2026

Media Spotlight | Making a Strong Start in the 15th Five-Year Plan: Jiangxi Integrates Bio-Industry Innovation to Build an “Accelerator” for Biopharmaceutical Innovation

Recent media reports indicate that Jiangxi Bio, leveraging the province’s first pilot-scale platform for biological immune antibody drugs, has achieved remarkable success in innovatively facilitating the critical translation of scientific research outcomes from the laboratory to industrial application.

See more+

< 1234...20 >

Contact us

Add:

Address: No. 198 Huoju Avenue, Jinggangshan Economic & Technological Development Zone, Ji’an, Jiangxi, China

Board Office:

Domestic Sales:

International Sales:

Complaint & Report Hotline:

Pharmacovigilance Hotline:

Company Email:

Investor Relations:

International Sales Email:

Complaint/Report Email:

二维码

WeChat mini-site

二维码

WeChat official account


© Copyright 2025 Jiangxi Institute of Biological Products Inc. | SEO

Business License

Powered by www.300.cn